HomeMRVL • CVE
add
Marvel Biosciences Corp
Previous close
$0.16
Year range
$0.060 - $0.19
Market cap
6.94M CAD
Avg Volume
36.59K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 222.59K | -49.08% |
Net income | -278.24K | 46.32% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 83.29K | -73.72% |
Total assets | 228.64K | -47.41% |
Total liabilities | 3.31M | 24.32% |
Total equity | -3.08M | — |
Shares outstanding | 44.79M | — |
Price to book | -2.21 | — |
Return on assets | -154.59% | — |
Return on capital | 44.73% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -278.24K | 46.32% |
Cash from operations | -262.48K | -9.53% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -262.48K | -9.53% |
Free cash flow | -145.41K | -1,933.42% |
About
Founded
2021
Headquarters
Website
